Drug Safety Labeling Changes
The summary view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. The “quick view” table below provides the drug name and sections modified. Click on the drug name to go to the detailed view. The detailed view includes sections and subsections modified, a description of new or modified safety information in the BOXED WARNING, CONTRAINDICATIONS, or WARNINGS sections, and a link to the revised prescribing information.
Key to Label Section Acronyms:
BW=BOXED WARNING, C=CONTRAINDICATIONS, W=WARNINGS, P=PRECAUTIONSAR=ADVERSE REACTIONS, PPI/MG=PATIENT PACKAGE INSERT/MEDICATION GUIDE
BW
C
W
P
AR
Concerta (methylphenidate HCl) Extended-Release Tablets
*risk of increased erections or priapism
Daytrana (methylphenidate transdermal system)
Focalin (dexmethylphenidate) tablets and Focalin XR (Dexmethylphenidate Hydrochloride) extended-release tablets
Metadate CD (methylphenidate HCl) Extended-Release Capsules
Methylin (methylphenidate) Oral Solution and Chewable Tablets
Quillivant XR (methylphenidate) extended-release oral suspension
Ritalin (methylphenidate hydrochloride) Tablets, Ritalin SR (Sustained-Release Tablets, and Ritalin LA Extended-Release Capsules
Adderall XR (mixed amphetamine salts) capsules
Desoxyn (methamphetamine hydrochloride) tablets
Dexedrine (dextroamphetamine sulfate) Spansule sustained release capsules
Lamictal (lamotrigine) tablets, chewable dispersible tablets
Lamictal ODT (lamotrigine) orally disintegrating tablets
Lamictal XR (lamotrigine) extended-release tablets
Vyvanse (lisdexamfetamine dimesylate) capsules
Zofran (ondansetron hydrochloride) Tablets, Oral Solution, Injection
Zofran ODT (ondansetron) Orally Disintegrating Tablets
Contact us to become a Sponsor